Cargando…
Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus
Both adaptive and innate immunity responses are necessary for the efficient elimination of different pathogens. However, the magnitude, quality and desired type of immune response specific to the co-administered antigen is largely determined by adjuvants. BC02 (BCG CpG DNA compound adjuvants system...
Autores principales: | Li, Junli, Fu, Lili, Guo, Xiaonan, Yang, Yang, Dong, Jiaxin, Wang, Guozhi, Zhao, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788605/ https://www.ncbi.nlm.nih.gov/pubmed/36560565 http://dx.doi.org/10.3390/vaccines10122155 |
Ejemplares similares
-
Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
por: Li, Junli, et al.
Publicado: (2022) -
Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice
por: Li, Junli, et al.
Publicado: (2023) -
Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021) -
Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
por: Ilyas, Sahrish, et al.
Publicado: (2020) -
Processing of virus-specific glycoproteins of varicella zoster virus
por: Namazue, Junko, et al.
Publicado: (1985)